Wave Life Sciences Announces Appointment of Jonathan Rosin as Chief Human Resources Officer
December 02, 2020 08:00 ET
|
Wave Life Sciences USA, Inc.
CAMBRIDGE, Mass., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people...
Wave Life Sciences to Present at the 29th Annual Credit Suisse Healthcare Conference
November 10, 2020 08:00 ET
|
Wave Life Sciences USA, Inc.
CAMBRIDGE, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people...
Wave Life Sciences Reports Third Quarter 2020 Financial Results and Provides Business Update
November 09, 2020 07:30 ET
|
Wave Life Sciences USA, Inc.
Results from all cohorts of PRECISION-HD1 and PRECISION-HD2 clinical trials and initial OLE data on track for 1Q 2021 Dosing in three new clinical trials with novel compounds incorporating PN...
Wave Life Sciences to Webcast Conference Call of Third Quarter 2020 Financial Results on November 9, 2020
October 26, 2020 16:05 ET
|
Wave Life Sciences USA, Inc.
CAMBRIDGE, Mass., Oct. 26, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people...
Wave Life Sciences to Present at the Chardan Virtual 4th Annual Genetic Medicines Conference
September 28, 2020 16:05 ET
|
Wave Life Sciences USA, Inc.
CAMBRIDGE, Mass., Sept. 28, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people...
Wave Life Sciences Prices $100 Million Public Offering of Ordinary Shares
September 23, 2020 07:00 ET
|
Wave Life Sciences USA, Inc.
CAMBRIDGE, Mass., Sept. 23, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people...
Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares
September 22, 2020 16:01 ET
|
Wave Life Sciences USA, Inc.
CAMBRIDGE, Mass., Sept. 22, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people...
Wave Life Sciences to Highlight Preclinical ADAR Editing Data and Neurology Programs at TIDES and OTS Annual Meetings
September 15, 2020 07:30 ET
|
Wave Life Sciences USA, Inc.
CAMBRIDGE, Mass., Sept. 15, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people...
Wave Life Sciences to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
September 10, 2020 16:25 ET
|
Wave Life Sciences USA, Inc.
CAMBRIDGE, Mass., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people...
Wave Life Sciences Reports Second Quarter 2020 Financial Results and Provides Business Update
August 10, 2020 07:30 ET
|
Wave Life Sciences USA, Inc.
Data from 32 mg cohorts of both PRECISION-HD trials and PRECISION-HD OLE trials expected in 1Q 2021 C9orf72 and SNP3 clinical trial applications on track to be submitted in 4Q 2020 ADAR editing...